Medication info

GC Wellbeing Aminoplex Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›0.69g / 100mLL-Leucine›0.91g / 100mLL-Lysine Acetate›1.02g / 100mLL-Methionine›0.53g / 100mLL-Phenylalanine›0.56g / 100mLL-Threonine›0.4g / 100mLL-Tryptophan›0.15g / 100mLL-Valine›0.66g / 100mLL-Arginine›0.95g / 100mLL-Histidine›0.28g / 100mLGlycine›1.4g / 100mLL-Alanine›0.71g / 100mLL-Proline›1.12g / 100mLL-Cysteine Hydrochloride Hydrate›0.024g / 100mLL-Serine›0.59g / 100mL
Manufacturer / importer
Nokchipsa Wellbeing Co., Ltd.
Appearance
Injection containing a colorless to light yellow transparent liquid in a multilayer film plastic container, made of polypropylene, intended for aqueous injection.
Packaging
For domestic use - 250 milliliters/box
Approval status
Active

MFDS item code 199200566 · Notified 1992.06.09

Summary

Main use
Improvement of nutrition through amino acid supplementation (e.g., for hypoproteinemia and malnutrition)
Who uses it
Adults · Children
Adult dosage
○Adults: Administer by intravenous infusion at a maximum daily dose of 1~1.5 g of total amino acids per kg of body weight. ○Rate of administration: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; in principle, administer by infusion at a rate of 30~40 drops per minute.
Children's dosage
For children, older adults, and burn patients with high protein requirements, adjust the dose and infusion rate before administration.

Ingredients

Manufacturer
Nokchipsa Wellbeing Co., Ltd.

Efficacy & effects

Improvement of nutrition through amino acid supplementation (e.g., for hypoproteinemia and malnutrition)

  • Hypoproteinemia
  • malnutrition
  • pre- and post-surgery
View approved original text

In cases of hypoproteinemia, malnutrition, or when amino acids are needed before and after surgery, the body's protein requirements increase, making amino acid supplementation important. Amino acids play an essential role in protein synthesis in the body, thus aiding in nutritional improvement and recovery. Therefore, amino acids are used to improve the physical condition in situations of hypoproteinemia, malnutrition, and pre- and post-surgery.

Dosage and Administration

Adult dosage

○Adults: Administer by intravenous infusion at a maximum daily dose of 1~1.5 g of total amino acids per kg of body weight. ○Rate of administration: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; in principle, administer by infusion at a rate of 30~40 drops per minute.

Children's dosage

For children, older adults, and burn patients with high protein requirements, adjust the dose and infusion rate before administration.

Precautions

This medication should be used under a doctor's direction. It should not be used in patients with hepatic coma or those at risk of hepatic coma. Patients with severely impaired kidney function or high blood urea nitrogen should not be administered this medication. Do not administer in patients with problems in nitrogen metabolism, severe heart failure, pulmonary edema, or very low or no urine output. If sodium or chloride ions are present, it is also contraindicated for patients with hypernatremia, hyperchloridemia, or alkalosis. In patients with severe acidosis, congestive heart failure, edema due to sodium retention, hyperkalemia or potassium retention, and hepatic or renal impairment, it should be used with caution. The sodium bisulfite included in this medication may cause allergic reactions, particularly increasing the risk of asthma attacks in asthmatic patients, warranting caution. If hypersensitivity reactions such as rashes occur during administration, use should be stopped immediately. Symptoms such as nausea, vomiting, chest discomfort, palpitations, rapid heartbeat, and increased blood pressure may occasionally occur. Rapid infusion in large doses can lead to acidosis, so caution is required. Other reported symptoms include chills, fever, headache, shortness of breath, shock, bronchospasm, and urinary tract spasms. Metabolic complications such as metabolic acidosis, hypophosphatemia, alkalosis, hyperglycemia, dehydration, hypoglycemia, elevated liver enzymes, vitamin imbalance, electrolyte abnormalities, and pediatric hyperammonemia may occur. In patients with impaired liver or kidney function, blood urea nitrogen (BUN) may increase, and patients with liver failure may exhibit blood amino acid imbalance, metabolic alkalosis, hyperammonemia, and consciousness disorders. Special care should be taken in maintaining electrolyte balance when administering large doses of this medication or using it with other electrolyte-containing solutions. Metabolic alkalosis may occur in overdose, so particular caution should be applied with preparations containing acetate ions. In patients with a history of kidney, lung, or heart disease, care must be taken to avoid excessive fluid overload. Blood glucose levels should be monitored closely when administering to diabetic patients. This medication may reduce protein-sparing effects when used with tetracycline-class drugs. The safety for pregnant women has not been established; it should only be administered when the therapeutic benefits outweigh the risks. In children, doses should be adjusted as liver function may be immature, and blood ammonia levels should be monitored frequently. Elderly patients may have reduced physiological capacity; thus, the infusion rate should be slow, and doses should be adjusted. As this medication contains electrolytes, special attention should be paid to maintaining electrolyte balance during large doses, and it should be administered via slow intravenous infusion. Rapid infusion may induce chills and vomiting and cause amino acid loss through the kidneys. It is advisable to warm the medication to body temperature before use and to prepare and handle it under aseptic conditions. The medication should not be used if discoloration, leaks, or precipitates are observed, and it should be used quickly after opening and stored within 24 hours. It is safest not to use products with damaged rubber stoppers. It is preferable not to use this medication in patients with a history of myocardial infarction.

Side effects

  • rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • hypertension
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary retention
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • reactive hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • loss of sensation
  • coma
  • anaphylactic shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid contact with air, at a temperature between 1 degree and 30 degrees Celsius. This way, the drug's efficacy can be well maintained and deterioration can be prevented.

Appearance and packaging

Appearance

Injection containing a colorless to light yellow transparent liquid in a multilayer film plastic container, made of polypropylene, intended for aqueous injection.

Package unit

For domestic use - 250 milliliters/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.